Ichor Holdings: Precision Fluid Delivery Solutions for the Semiconductor Industry

Ichor Holdings designs, engineers, and manufactures critical fluid delivery subsystems and components for semiconductor capital equipment. The company's products include precision gas and chemical delivery systems, weldments, and modular subsystems that are integral to the deposition and etch tools used in semiconductor fabrication. Customers include major OEMs such as Applied Materials, Lam Research, and Tokyo Electron, which integrate Ichor's subsystems into their wafer processing equipment.

The company generates revenue through two primary product lines: fluid delivery subsystems (gas panels, chemical delivery modules) and precision components (fittings, regulators, and weldments). Approximately 85% of revenue is tied to semiconductor capital equipment, with the remainder derived from aftermarket spares and services. Ichor operates manufacturing facilities in the United States, Singapore, Malaysia, and Mexico, serving a global customer base. In 2025, the company reported revenue of approximately $820M, reflecting the cyclical downturn, with the majority of sales concentrated among the top five OEM customers.

Near-Term (2026): The primary growth driver is the recovery in WFE spending, with leading foundry/logic customers resuming capacity additions and memory makers increasing investment in HBM-related capacity. We expect ICHR's revenue to grow 25-30% in 2026, reaching approximately $1.05B, as utilization rates improve and order book conversion accelerates.

Medium-Term (2027-2028): Structural growth drivers include the ramp of GAA production at multiple foundries, which requires more deposition/etch steps per wafer; expansion of advanced packaging capacity for AI accelerators; and increasing adoption of ICHR's new high-purity products for EUV-related applications. Additionally, the company's M&A strategy is expected to contribute 5-8% incremental growth annually. We project a 15% CAGR in revenue over 2026-2028, reaching approximately $1.4B by 2028.

International Expansion: China-related revenue, which grew during the 2024-2025 export control period, is expected to moderate but remain a meaningful contributor. ICHR is also investing in local manufacturing capacity in Southeast Asia to support customer diversification and supply chain resilience requirements.

The 2025 fiscal year represented the cyclical trough, with revenue declining approximately 20% as customers paused equipment orders. The GAAP loss of $1.17 per share included restructuring charges and inventory write-downs related to the downturn. As volumes recover in 2026, we expect meaningful operating leverage, with gross margins expanding 170 basis points on improved factory utilization and a more favorable product mix. By 2027, we model EPS of $1.85, approaching peak-cycle earnings power of approximately $2.50 per share achieved in 2022.

The semiconductor capital equipment market is projected to grow from approximately $95B in 2025 to $125B by 2028, driven by AI-related demand, the proliferation of advanced packaging, and the build-out of new fabs globally. Within this market, the precision subsystems segment that Ichor serves is estimated at $2.0-2.5B, growing at a 12-15% CAGR as tool complexity increases.

ICHR's competitive position is strong, with an estimated 70% share of precision fluid delivery subsystems in deposition and etch tools. Key competitors include:

• Ultra Clean Holdings (UCTT): A direct competitor with a broader product portfolio including gas delivery systems and components, estimated at 20-25% market share.
• MKS Instruments (MKSI): Competes in adjacent vacuum and gas delivery technologies, with a focus on integrated solutions.
• Brooks Automation (AZTA): Provides automation and contamination-control solutions, overlapping in precision components for semiconductor tools.

ICHR differentiates through engineering expertise in high-purity fluid handling, manufacturing scale, and deep customer relationships with OEMs. The primary competitive risk is vertical integration by large OEMs or in-sourcing by customers, though switching costs and ICHR's cost advantage have historically mitigated this risk.

Discounted Cash Flow Analysis: We construct a DCF model using a 10% WACC (reflecting ICHR's beta of 1.85 and moderate leverage) and a 2.5% terminal growth rate. Our base case projects revenue growing at a 15% CAGR through 2028, with EBITDA margins expanding to 20% by 2028. This yields a fair value of approximately $68 per share, implying a 20% upside from the current price of $56.29.

Comparable Company Analysis:

On 2026 estimates, ICHR trades at a slight discount to the comparable average on EV/EBITDA, which we view as unwarranted given the company's higher growth trajectory and market share position. Applying a 15x EV/EBITDA multiple to our 2026 EBITDA estimate of $157M yields an equity value of approximately $2.55B, or $68 per share, consistent with our DCF analysis.

Cyclicality of Semiconductor Capital Equipment: ICHR's revenue is highly correlated with WFE spending, which can swing 20-30% annually. A slower-than-expected recovery or a new downturn in 2027 would materially impair our estimates. The stock's beta of 1.85 amplifies this cyclical risk.

Customer Concentration: The top five OEM customers account for over 80% of revenue. Loss of a major customer or a shift in OEM in-sourcing strategy could have a severe impact on financial results.

Geopolitical and Export Control Risk: Restrictions on semiconductor equipment sales to China, which represented a meaningful portion of 2024-2025 demand, could reverse or expand, affecting ICHR's order book. Conversely, further restrictions could benefit ICHR if domestic (US) fab construction accelerates.

Margin Pressure from Competition: While ICHR holds a dominant share, competitive pricing pressure from UCTT and others could limit gross margin expansion. Additionally, rising raw material costs (specialty metals, electronics) could compress margins if not passed through to customers.

Integration Risk from M&A: The company's growth strategy relies partly on acquisitions. Poor integration, cultural mismatch, or overpayment for targets could destroy value and distract management from core operations.